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A B S T R A C T Sympathetic activity in rats and mice is diminished by fasting and increased by sucrose feeding. The central neural mechanisms coordinating changes in the functional state of sympathetic nerves with changes in dietary intake are unknown, but a role for neurons in the ventromedial hypothalamus (VMIH) is suggested by the existence of sympathetic connections within the VMH and the importance of this region in the regulation of feeding behavior. To investigate the potential role of the VMH in dietary regulation of sympathetic activity [3H]norepinephrine turnover was measured in the hearts of fasted and sucrose-fed mice after treatment with gold thioglucose (AuTG). In control mice, norepinephrine (NE) turnover was 1.60+0.92 ng NE/heart per h (95% confidence limits) after 1 d of fasting and 4.58+0.98 after 3 d of sucrose feeding, although, in AuTG-treated mice, cardiac NE turnover in fasting was 5.45+1.56 and with sucrose feeding, 5 .44 +0.76. Experiments with ganglionic blockade indicate that the absence of dietary effect on NE turnover in AuTG-treated mice reflects a corresponding lack of change in central sympathetic outflow. AuTG administration, therefore, disrupts dietary regulation of sympathetic activity by abolishing the suppression of sympathetic activity that occurs with fasting. This effect of AuTG is unrelated to duration of fasting (up to 3 d) and is specific for AuTG because neither treatment with another gold thio compound (gold thiomalate) nor the presence of genetic obesity (ob/ob) prevented fasting suppression of sympathetic activity. Moreover, AuTG treatment did not impair sympathetic activation by cold exposure (4°C) nor adrenal medullary stimulation by 2-deoxy-D-glucose. Thus, AuTG treatment selectively impairs dietary regulation of sympathetic activity, possibly by destruction of neurons in the VMH.
INTRODUCTION
Previous studies from our laboratory have demonstrated that, in the rat, changes in sympathetic activity occur Receivedfor publication 24 July 1979 and in revisedform 14 January 1980. 1086 with changes in diet: fasting decreases and sucrose feeding increases the functional state of sympathetic nerves in heart, pancreas, and liver (1) (2) (3) . Although the mechanisms involved in coupling sympathetic activity with changes in diet are unknown, recent evidence suggests that this regulatory process is distinct from adrenal medullary stimulation by hypoglycemia (4) . Because the autonomic adjustments to a variety of environmental changes are coordinated within the hypothalamus, alterations in sympathetic activity induced by diet are likely to be governed, in part, by hypothalamic centers. One region of the hypothalamus in particular, the ventromedial hypothalamus (VM H),1 has connections with sympathetic centers in the brainstem (5) and participates in the control of feeding behavior (6) . Moreover, both electrical activity within the VMH and the rate of release of endogenous catecholamine neurotransmitters from this region are affected by nutritional state and by acute changes in circulating concentrations of insulin and glucose (7, 8) . In addition, diminished sympathetic activity after electrolytic destruction of the VMH has been inferred from studies of the lipolytic response to various stimuli, including fasting (9, 10) . These considerations, therefore, suggest a potential role for the VMH in the regulation of sympathetic activity by diet.
To investigate the possibility that the VMH is involved in dietary-induced changes in sympathetic activity, the effects of dietary manipulations on the sympathetic nervous system have been studied in mice treated with gold thioglucose (AuTG), a compound that destroys the VMH (11) . Sympathetic activity in the hearts of AuTG-treated mice has been assessed by measurement of [3H]norepinephrine turnover. This technique depends upon the amine transport system of the axonal membrane to introduce tracer norepinephrine (NE) into the endogenous catecholamine stores within the sympathetic nerve endings (12) . After equilibration with stored NE, the tracer is released along with endogenous NE and becomes a valid marker of NE release (13) . Quantitation of the rate of disappearance of tracer, expressed as the rate of change of specific activity of NE, permits statistical comparison of sympathetic activity under different experimental conditions. Because release of NE depends upon sympathetic nerve impulses, more rapid release, reflected in a faster turnover, indicates increased sympathetic activity, and decreased turnover implies decreased sympathetic activity.
The results reported in this paper indicate that, in contrast to dietary modulation of sympathetic activity in the hearts of normal mice, AuTG-treated mice fail to display changes in sympathetic activity in heart with changes in diet; suppression of sympathetic activity by fasting is abolished by AuTG treatment. Sympathoadrenal responses to other, non-nutritional stimuli, such as cold exposure and 2-deoxy-D-glucose administration, are unaffected by AuTG. These results imply an important role for AuTG-sensitive neurons (possibly within the VMH) in dietary regulation of sympathetic activity in the mouse.
METHODS
Female CD-1 mice (20-25 g ) obtained from Charles River Breeding Laboratories (Wilmington, Mass.) and C57B1/6J-ob obese (ob/ob) and phenotypically lean (+/?) mice (8-10 wk of age) obtained from The Jackson Laboratory (Bar Harbor, Maine) were housed, 10 per cage, in a constant temperature animal room (20°C) and allowed free access to water and Charles River chow (R-M-H 3000; Agway-Country Foods, Agway Inc., Syracuse, N. Y.), except where noted. WVhile fasting, the animals were permitted free access to a hypotonic electrolyte solution of Na+ (78 meq/liter) and K+ (15 meq/liter) and, during sucrose feeding experiments, to a 10% sucrose solution supplementing the standard lab chow diet.
AuTG-obese mice were developed from the CD-1 strain. AuTG (Sigma Chemical Co., St. Louis, Mo.) was dissolved in isotonic saline and administered intraperitoneally in a dose of 800 mg/kg. Because the effects of AuTG are not uniform throughout a group of treated mice, the subsequent development of obesity was employed as an in vivo estimate of VMH destruction. 6-8 wk after injection, the surviving AuTG-treated (60-70% of those injected) and previously uninjected control mice were weighed; those AuTG-treated mice weighing >4 SD above the mean weight of the control mice were selected for study. Gold thiomalate (AuTM; Myochrysine, Merck Sharp & Dohme Div., West Point, Pa.) was dissolved in isotonic saline and injected intraperitoneally in an equivalent gold dosage to AuTG. Animals were studied 7 wk later. Chlorisondamine (Ciba-Geigy Corp., Pharmaceuticals Div., Summit, N. J.) and 2-DG (Sigma Chemical Co.) were dissolved in isotonic saline and injected intraperitoneally in doses of5 and 500 mg/kg, respectively.
Colonic temperature was measured with a rectal probe attached to a Yellow Springs telethermometer (Yellow Springs Instruments Co., Yellow Springs, Ohio). The plastic-coated thermistor was dipped in mineral oil and inserted 2 cm into the (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) Ci/mmol sp act; New England Nuclear, Boston, Mass.) was purified before use by column chromatography with alumina as described below. The [3H]NE was diluted to an appropriate concentration with isotonic saline, and injected intraperitoneallv at the start of each turnover studv. The dose of [3H]NE employed in these studies varie(d between 250 and 340 uCi/cm3 (-1-2 ,ug NE/kg)2. The mice were killed at preselected times by cervical dislocation. For each time point in the studies of NE turnover, 4-7 animals were killed from each experimental group, totaling 17-25 animals per turnover line. The organs were rapidly removed, frozen on dry ice, and stored at -20°C for later processing (usuallv vithin 2 wk). The tissues to be analyzed for NE (and for epinephrine [E] where indicated) were homogenized in iced 0.4 N perchloric acid in a ground glass homogenizer (Kontes Glass Co., Vineland, N. J.) to extract the NE and precipitate the proteins. After volume adjustment, the precipitated protein was removed by low-speed centrifugation.
Isolation of NE (and E) from the perchloric acid extract was by column chromatography with alumina as previously described (15) . NE (and E) was absorbed onto the alumina column at pH 8.6 and eluted with 3.0 ml 0.2 N acetic acid. The alumina (Woelm neutral; ICN Nutritional Biochemiicals, Cleveland, Ohio) had previously been purified according to the method of Anton and Sayre (16) . Recovery of added NE or E was usually in excess of 60% vith a variation betveen columns of <10%; the results were corrected for recovery as determined in each experiment. Assay of NE (and of E where appropriate) on the alumina eluate was by a modification ofthe spectrophotofluorometric method of Crout (17) . Aliquots ofthe alumina eluates were counted for [3H]NE by liquid scintillation spectrometry in a Nuclear-Chicago three-channel scintillation counter (Nuclear-Chicago Corp., Des Plaines, Ill.) (15) . Efficiency for 3H in this svstem is 6-8%.
Data are presented as mean ±SEM, unless otherwise noted. Statistical analyses used the t test for unpair'ed variables in twotailed tests ofthe null hypothesis. In the studies of NE turnover, the data were plotted semilogarithmically. The slope ofthe decline in NE specific activity over time after [3H]NE administration was calculated by the least squares method. The endogenous NE level remained constant over the course ofthe turnover experiments. NE turnover rates were calculated as the product of the fractional turnover rate and the endogenous NE concentration (13) . 95% confidence intervals were determined for the NE turnover rates as previously described (18) . Comparison of fractional turnover rates was made with the t test.
RESULTS
Effect offasting and sucrosefeeding on NE turnover in control and AuTG-treated mice. In the rat, sympathetic activity is decreased by fasting and increased by sucrose feeding (1-3). As shown in Fig. 1 (Fig. 3) . In control animals, fasting decreased NE turnover as before; t1/2 increased from 6.9 to 12.1 h, k decreased from 10.0+0.6 to 5.75±0.65%/h (P < 0.001), and the calculated NE turnover rate fell from 14.5±1.4 to 9.29±1.34 ng NE/heart per h. As noted in the text, the slope or k differed significantly between control and fasted animals (P < 0.02) and between control and sucrose-fed mice (P < 0.005). Calculated NE turnover rates differed significantly between fasted and sucrose-fed animals.
increase in k to 7.62+0.68%/h (P < 0.005 compared with control). Calculated NE turnover rate was lowest with fasting, 0.80+0.52 ng NE/heart per h (95% confidence limits), and highest with sucrose feeding, 3.06±0.52 ng NE/heart per h. Thus, the dietary manipulations of fasting and sucrose feeding produce changes in cardiac sympathetic activity in mice that parallel those seen previously in rats.
The effect of AuTG-treatment on dietary alterations in sympathetic activity was investigated in a similar manner. As shown in Fig. 2 , cardiac NE turnover was measured in AuTG-treated mice and in a simultaneously studied group of nontreated, control mice from the original cohort. Fasting began 24 h and sucrose feeding 72 h before the start ofthe turnover experiment and continued for the duration of the study. As in the previous experiment, in control mice tl2 was markedly prolonged in fasted animals (40.2 h) compared with sucrose-fed animals (11.4 h); k was less in fasted mice, 1 Effect of ganglionic blockade on NE turnouer in fasted and sucrose-fed control and AuTG-treated mice. Evidence that this effect of AuTG treatment to abolish dietary alterations in cardiac NE turnover represents a change in the regulation of central sympathetic oufflow is presented in Fig. 4 . Because NE turnover reflects central sympathetic outflow, the imposition of ganglionic blockade produces a greater effect on NE turnover in situations ofincreased sympathetic activity and, conversely, a lesser effect under conditions of decreased sympathetic activity. In previous studies with fasted and sucrose-fed rats, the introduction of ganglionic blockade with chlorisondamine after administration of tracer [3H]NE led to smaller increases in the retention of tracer in the hearts of fasted animals, and to greater increments in retained tracer in the hearts of sucrose-fed animals, as compared with control, ad lib fed animals (1, 2) ; these changes are consistent with a decrease in central sympathetic outflow during fasting and an increase during sucrose feeding. A similar experiment in fasted and sucrose-fed control mice is shown in Fig. 4A Effect offasting and sucrosefeeding on NE turnover in AuTM-treated mice. To examine the possibility that the influence of AuTG administration on dietary changes in sympathetic activity was the result of nonspecific effects of gold, NE turnover was measured in fasted and sucrose-fed mice treated 7 wk previously with an equivalent dose of gold in the form ofAuTM. In contrast to AuTG, AuTM does not produce an obesity syndrome (19) . The effects of fasting (24 h ) and sucrose feeding (72 h) on cardiac NE turnover in AuTM-treated mice are shown in Fig. 5 . In fasted mnice, tl2 was longer than in sucrose-fed animals (15.1 and 4.8 h, respectively), k was lower (4.58±+ 1.09 and 14.4±+ 1.37%/h, P < 0.001), and calculated NE turnover rate was reduced (3.00+0.92 and 7.42±+1.46 ng NE/heart per h, 95% confidence limits). AuTM administration, thus, did not affect dietary regulation of sympathetic activity, indicating that the lack of fasting suppression of sympathetic activity seen in AuTG-treated mice is not a nonspecific effect of gold administration. Effect offasting and sucrosefeeding on NE turnover in control anid genetically obese (oblob) imice. To investigate whether obesity per se alters dietary regulation of sympathetic activity, the influence of dietary manipulations on NE turnover was assessed in a different imiouse moldel of obesity, the genetically obese ob/ob mouse, and in its phenotypically lean control strain (+/?). The effects of prior fasting (24 h) and sucrose feeding (72 h) on cardiac NE turnover in control and ob/ ob mice are shown in Fig. 6 . The weights of the ob/ob mice were comparable with those of the AuTG-treated mice in previous experiments, averaging 40-45 g. In both control and ob/ob mice, NE turnover in fasted animals was significantly less than in sucrose-fed mice.
The tl2 of cardiac NE was prolonged by fasting in both lean controls and ob/ob mice, compared with sucrosefed animals (from 6.4 to 12.4 h in control mice and from 7.5 to 14.9 h in the ob/ob mice). k were slower in fasted than in sucrose-fed mice (5.64+1.75%/h in fasted controls and 10.9+1.58%/h in sucrose-fed iice [P < 0.05], and 4.65± 1.20%/h in fasted and 9.23± 1.24%/h in sucrose-fed ob/ob imiice [P < 0.02]) and the calculated NE tumover rates were also different (4.09±1.36 ng NE/ heart per h [95% confidence limits] in fasted lean control mice compared with 6.72±1.21 ng NE/heart per h in sucrose-fed controls, 3.35±0.95 in fasted mice, and 6.67±1.23 ng NE/heart perh in sucrose-fed ob/ob mice). Thus, the demonstration of similar changes in cardiac sympathetic activity with fasting and sucrose feeding in control and ob/ob mice indicates that the absence of dietary alteration in cardiac sympathetic activity in AuTGtreated mice cannot be attributed to obesity itself.
Effect ofcold exposure on NE turnover in control and AuTG-treated in ice. The lack of diet-induced change in sympathetic activity in AuTG-treated mice could represent a general defect in symnpathetic regulation. To examine the sympathetic nervous system response to a nondietary stimulus, NE turnover was assessed in control and AuTG-treated mice exposed to a cold (4°C) environment (Fig. 7) . In this experiment [3H]NE was injected into control and AuTG-treated mice. 30 min after injection, half of the mice in each group were placed in the cold. At the end of the experiment the residual tracer [3H]NE was significantly less in the hearts of both cold-exposed control and cold-exposed AuTGtreated mice, compared with the corresponding ambient temperature animals. Because both groups ofcontrol and AuTG-treated mice were identical at the beginning of the experiment, the lower tracer content in the hearts of cold-exposed mice at the end of the study reflects increased NE turnover. Thus, activation of the sympathetic nervous system by cold exposure is not affected by prior treatment with AuTG. Effect of2-DG administration on adrenal E content in control and AuTG-treated mice. Because glucose is a potential signal in the coupling of sympathetic activity with nutrient intake, the possibility of a AuTGinduced impairmnent in response to hypoglycemia was investigated using 2-DG, a nonmetabolizable glucose analogue known to stimulate the adrenal medulla by neural mechanisms generally accepted as resembling those activated by hypoglycemia (20, 21) . After 2-DG administration, the E content was measured in adrenal glands of control and AuTG-treated mice removed 3 h after injection (Table I) (7) 4.10+0.46 (7)t To mice fed ad lib., 2-DG (500 mg/kg) was administered i.p., and the animals were killed 3 h later. Data are presented as mean+SE M. The numbers in parentheses represent the number of animals in each group. * P < 0.1, 2-DG vs. saline.
t P < 0.001, 2-DG vs. saline.
lowered adrenal E 24% in control mice (P < 0.1) and 33% in AuTG-treated mice (P < 0.001). Thus, the adrenal medullary response to 2-DG is not inhibited by prior administration of AuTG. Effect offasting on colonic temperature in control and AuTG-treated mice. A physiologic concomitant of the lack of suppression of sympathetic activity with fasting after AuTG is provided by measurement of colonic temperature in fed and fasted control and AuTGtreated mice (Table II) . Control mice fasted for 1 d had colonic temperatures 0.5°C lower than fed animals (P < 0.001). In AuTG-treated mice, colonic temperatures were unaffected by 2 d of fasting, although basal temperatures in fed AuTG mice were 0.40C below the fed controls (P < 0.01). Although the decrease in colonic temperature with fasting in control mice is multifactorial, sympathetic nervous system suppression plays at least a permissive role because sympathetic activation is a major defense against hypothermia in intact, fed animals. The lack of change in colonic temperature in AuTG-treated mice with fasting is consistent with the failure of sympathetic suppression during fasting described above. Symnpathetic Activity in Gold Thioglucose-treated Mice DISCUSSION Normal rats and mice consistently suppress sympathetic activity with fastinig; this study demonstrates that fasting is without effect on cardiac sympathetic activity in AuTG-treated obese mice. The absence of sympathetic suppression with fasting is not influenced by the duration of the fast (up to 48 h before the turnover study), and cannot be explained by the nonspecific effects ofeither gold administration or obesity. The specificity of the AuTG lesion for dietary regulation of sympathetic activity is further emphasized by the normal sympathoadrenal responses of the AuTG-treated obese animal to cold exposure and to 2-DG administration, indicating that AuTG treatment does not result in a general paralysis of sympathoadrenal outflow. Thus, the failure of AuTG-treated mice to suppress cardiac sympathetic activity with fasting appears to be the consequence of specific effects of AuTG on the coupling of sympathetic activity and diet.
As in our previous studies, symipathetic activity has been assessed by measurement of the cardiac NE turnover rate using tracer [3H]NE (1-3). Although this method for measuring sympathetic activity is subject to several theoretical limitations (3), to the extent that they apply, these limitations affect the sensitivity rather than the validity of the technique. Furthermore, there is no reason to assume that the importance of these factors is specifically and uniquely greater in the AuTG-treated mouse than in control or genetically obese mice. The results of the experiments with ganglionic blockade (Fig. 4) , moreover, support the use of NE turnover rates to estimate changes in central sympathetic outflow in the AuTG-treated mouse.
The locus of the lesion(s) responsible for the observed impairment in dietary regulation of sympathetic activity in the AuTG-treated mouse is uncertain. AuTG administration destroys a portion of the VMH, the extent of destruction in normal mice being determined by the amount of AuTG injected. Ablation of the VMH in our AuTG-treated mice can be assumed because of the recognized association between AuTG-induced obesity and VMH damage (22) (23) (24) and because of previously demonstrated, complete VMH destruction after a AuTG dose 25% less than that employed in these experiments (25) . AuTG, however, produces pathologic lesions in the brain beyond that in the VMH. Other regions of the hypothalamus as well as extrahypothalamic sites within the central nervous system specifically accumulate AuTG and undergo pathologic changes (26, 27) . One such lesion, that in the dorsal motor nucleus of the vagus, has also been associated with AuTG-induced obesity in mice.4 Thus, although the coordination of sym- pathetic activity with dietary intake is presumed to occur within the hypothalamus as it does for integration of sympathetic activity with other physiological phenomena, such as temperature regulation, the studies reported here, although consistent with a primary role for the hypothalamus, do not provide definitive localization of the region(s) involved.
A model of dietary regulation of sympathetic activity incorporating the observation of impaired suppression of sympathetic activity with fasting in AuTG-treated mice is presented in Fig. 8 . In this model, the brainstem centers that ultimately determine central sympathetic outflow receive descending inhibitory input from more rostral regions in the central nervous system; fasting increases this inhibition and overfeeding sucrose decreases it relative to the ad lib. feeding state.
The destruction by AuTG of these higher neurons, possibly within the VMH, removes this inhibitory influence on the brainstem centers. Thus, disinhibition of the brainstem centers by AuTG treatment establishes sympathetic activity at the level usually found in sucrose-fed control animals, regardless of the dietary intake of the lesioned animals. As proposed in Fig. 8 , the regulatory organization of the sympathetic nervous systemn resembles that described by Sherrington (28) for the motor system. In both cases, lower level, tonically active neurons are inhibited by descending impulses from higher centers.
Indirect support for the model in Fig. 8 is available from studies of thermogenic responses to cold exposure. Malnourished human infants and acutely starved, preweanling rats fail to increase oxygen consumption normally upon exposure to environmental temperatures of 20°-30°C (29, 30) . In rats, this metabolic restraint of fasting is eliminated by surgical decerebration, indicating the presence of descending inhibitory input in these fasting animals (31) . Because the role of sympathetic activation in promoting heat production (oxygen consumption) in the defense against environmental cold is well recognized (32) , such data in fasted, coldexposed rats are consistent with the model shown in Fig. 8 This model ofa potential role for the VMH in regulating sympathetic activity in accord with dietary intake is at variance with one recently proposed by Bray and York (33) in which destruction of the VMH is said to reduce sympathetic activity. In the studies upon which their hypothesis is based (9, 10), impaired sympathetic activation was inferred from estimates of the lipolytic response to a variety of conditions. The presence of hyperinsulinemiia in the VMH-lesioned animals, however, would appear to weaken the connection between lipolysis and sympathetic activity sufficiently so that fat mobilization could not serve as a reliable index of sympathetic activity. On the other hand, the stuidies reported here, although measuring sympathetic activity directly, did so only in heart. Conceivably, sympathetic outflow to adipose tissue and other areas may be affected differently than heart, althouigh such nonhomogeneity in sympathetic activity after rather gross ablative procedures would seemn unlikely.
The connection between impaired dietary regulation of sympathetic activity in AuTG-treated mice and the subse(qtient development ofobesity is unclear. Because catecholaimines increase heat production, chroniic stimulation of syinpathetic activity, if present in organs other than the heart, might be expected to increase the dissipation of ingested calories as heat and thereby limit weight gain. The lack of variation in symlpathletic activity otherwise associated with intermiiittenit feeding and fasting might, however, lead to diminished sensitivity to the thermogenic effects of catecholamines. Although adipose tissue from AuTG-obese mice exhibits an impaired lipolytic response to E in vitro (34) , fuirther studies are required to define the extent and to explore the imiplications of this potenitial alteration in end-organ response to catecholamines in AuTG-treated mice.
